Izumi Finance vs Enzyme — how do they compare? Izumi Finance trades at Rp26.85 (market cap Rp32,06M, Rp254,85jt 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 4.2× Izumi Finance's market cap, and Izumi Finance's supply is capped (787,4M / 2B IZI (40%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Izumi Finance for 10 Days and Enzyme for 28 Days on average.
| IZI | MLN | |
|---|---|---|
Market Cap | Rp32,06M | Rp134,13M |
Volume (24h) | Rp254,85jt | Rp104,56M |
Circulating Supply | 787,4M / 2B IZI (40%) | 3,3M MLN |
Typical Hold Time | 10 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Izumi Finance (IZI) holds a market cap of Rp32.06M with a circulating supply of 787.4 million tokens out of a 2 million max supply, indicating a 40% circulation rate. Current price data is unavailable, but the token shows a hold time of 10 days, suggesting moderate trader retention. No recent protocol updates or ecosystem news are noted, with technical analysis limited due to missing price metrics.
Overall outlook is cautious due to low market cap and limited liquidity. Key opportunities include potential ecosystem growth if adoption increases, but major risks involve high volatility from low trading volume and regulatory uncertainties in the crypto space. Investors should monitor on-chain activity for signs of network engagement.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Izumi Finance provides Programmable Liquidity as a Service (LaaS) on Ethereum with Uniswap V3 and plans to expand to multiple chains with integrated DEXs. This service allows liquidity providers to earn extra liquidity mining rewards and trading fees. It also helps protocols attract and maintain liquidity effectively. Izumi improves incentive distribution through its LiquidBox, allowing rewards to be allocated within specific price ranges.
Read more on IZI →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →